Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C O Callender

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Immunological Communications|January 1, 1974
Failure of pepsin-digested donor specific alloantibody to prolong renal allograft survival in dogsC O Callender, D E Sutherland, R J Howard, et al.
Transplantation Proceedings|January 1, 1998
A comparison study of the Belzer machine preservation solution with and without penicillinF Gage, D Y Barhyte, A E Kowalski, et al.
Minnesota Medicine|June 1, 1975
Factors determining early kidney functionL H Toledo-Pereyra, A W Moberg, C O Callender, et al.
Clinical Transplantation|December 1, 1996
A new approach for increasing the organ supplyA E Kowalski, J A Light, W O Ritchie, et al.
Transplantation Proceedings|February 1, 1989
Renal transplantation in substance abusers revisited: the Howard University Hospital experienceD John, C O Callender, J Flores, et al.
Obstetrics and Gynecology|May 1, 1984
Successful pregnancy with sickle cell disease and renal transplantationL S Westney, C O Callender, J Stevens, et al.
Transplantation|October 1, 1973
Prolongation of kidney allografts perfused by antilymphocyte globulin in vitroC O Callender, R L Simmons, L H Toledo-Pereyra, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1973
Mixed leucocyte culture, pre- transplant transfusions and renal allograft rejectionA R Shons, E E Etheredge, C O Callender, et al.
Clinical Transplants|January 1, 1995
How should cadaver-donor kidneys be allocated in the United States?J S Wolf, C O Callender, P I Terasaki, et al.
Surgery|May 1, 1973
Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosisJ O Ruiz, R L Simmons, C O Callender, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Immunological Communications|January 1, 1974
Failure of pepsin-digested donor specific alloantibody to prolong renal allograft survival in dogsC O Callender, D E Sutherland, R J Howard, et al.
Transplantation Proceedings|January 1, 1998
A comparison study of the Belzer machine preservation solution with and without penicillinF Gage, D Y Barhyte, A E Kowalski, et al.
Minnesota Medicine|June 1, 1975
Factors determining early kidney functionL H Toledo-Pereyra, A W Moberg, C O Callender, et al.
Clinical Transplantation|December 1, 1996
A new approach for increasing the organ supplyA E Kowalski, J A Light, W O Ritchie, et al.
Transplantation Proceedings|February 1, 1989
Renal transplantation in substance abusers revisited: the Howard University Hospital experienceD John, C O Callender, J Flores, et al.
Obstetrics and Gynecology|May 1, 1984
Successful pregnancy with sickle cell disease and renal transplantationL S Westney, C O Callender, J Stevens, et al.
Transplantation|October 1, 1973
Prolongation of kidney allografts perfused by antilymphocyte globulin in vitroC O Callender, R L Simmons, L H Toledo-Pereyra, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1973
Mixed leucocyte culture, pre- transplant transfusions and renal allograft rejectionA R Shons, E E Etheredge, C O Callender, et al.
Clinical Transplants|January 1, 1995
How should cadaver-donor kidneys be allocated in the United States?J S Wolf, C O Callender, P I Terasaki, et al.
Surgery|May 1, 1973
Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosisJ O Ruiz, R L Simmons, C O Callender, et al.
Pageof 8